Thaver

Market Fit & Due Diligence

Make your move with clarity and confidence.

Before committing significant resources to a new business, you need a clear understanding of the opportunity.

Thaver partners with investors and businesses to assess real market validity, the competition landscape and commercial risks to help you make informed decisions before you move.

For Established Companies

See the full picture.

Whether you’re exploring an acquisition, new product or in-licensing, we provide the insights to back your decisions.

For Start Ups

Leave nothing to chance.

Our guidance and framework ensure every element of your launch is backed by evidence.

Commercial & Market Validation

Clarity without the guesswork.

Assess the market

A strategic and confident assessment of gaps and opportunities within your target market.

Know the competition

A comprehensive understanding of your key competitors and how to position yourself in the market.

From risk to readiness

Potential commercial and operational challenges identified, before they become problems.

Why Thaver

Validate

Commercial viability of £25M+ opportunities

Identify

Critical commercial risks before scale

Build

Evidence-backed early pipeline (£5M–£15M)

Accelerate

Time-to-market by 3–9 months globally

FAQS

What is commercial due diligence in life sciences?

Commercial due diligence in life sciences evaluates whether a healthcare or biotech opportunity has real market demand, competitive differentiation, and viable revenue potential. It tests assumptions about customers, pricing, market size, and go-to-market strategy before investors or acquirers commit capital. 

Why is market validation important before investing in a healthcare or biotech company?

Market validation confirms whether a product or technology solves a real market need and has paying customers. Without validating demand, companies risk investing in innovations that are scientifically strong but commercially unviable or poorly positioned in the market. 

How do investors assess commercial risk in life sciences deals?

Investors assess commercial risk by analysing market size, buyer demand, competitive landscape, pricing power, and sales execution capability. Commercial due diligence helps identify revenue forecast risks, adoption barriers, and market entry challenges before completing a deal. 

What does a life sciences commercial due diligence process typically include?

A typical commercial due diligence process includes market opportunity analysis, customer and stakeholder interviews, competitive positioning assessment, pricing evaluation, and review of the company’s commercial model and go-to-market strategy.